3-Bromo-4-isobutoxybenzothioamide

We are 3-Bromo-4-isobutoxybenzothioamide CAS:208665-96-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Bromo-4-isobutoxybenzothioamide
CAS.NO:208665-96-7
Synonyms:3-Bromo-4-isobutoxybenzothioamide
3-bromo-4-(2-methylpropoxy)benzenecarbothioamide
3-broMo-4-(2-Methylpropoxy)benzene-1-carbothioaMide
3-bromo-4-isobutoxy-benzenecarbothioamide
 
Physical and Chemical Properties:
Density 1.398 g/cm3
Boiling Point 370.783ºC at 760 mmHg
Molecular Formula C11H14BrNOS
Molecular Weight 288.20400
 
Specification:
Appearance:Yellow or yellow-green powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Febuxostat(CAS:144060-53-7).

3-Bromo-4-isobutoxybenzothioamide


Related News: This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.145514-62-1 At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase.11099-06-2 The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.2,6-diaminotoluene The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300.

Related Products
Product Name
tert-butyl 3-[(4-aminophenyl)methyl]piperidine-1-carboxylate View Details
3-bromopyridine View Details
N-Hydroxy-5-norbornene-2,3-dicarboximide View Details
1-Carboxy-1-methylethoxyammonium chloride manufacturer 2-Chloro-5-fluoro-3-methylpyridine manufacturer 3-Amino-4-fluorobenzoic acid manufacturer 2,2′-Dithienyl Disulfide manufacturer N-Benzyl-N-methylethanolamine manufacturer